Published in Cancer Res on November 15, 1996
Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol (2002) 1.76
Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms. Carcinogenesis (2008) 1.69
Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer (2000) 1.46
Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis (1999) 1.42
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. Br J Cancer (2006) 1.39
Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer (2006) 1.32
COX inhibitors and breast cancer. Br J Cancer (2006) 1.27
CK1epsilon is required for breast cancers dependent on beta-catenin activity. PLoS One (2010) 1.22
Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells. Breast Cancer Res (2005) 1.21
Cannabinoids and cancer: pros and cons of an antitumour strategy. Br J Pharmacol (2006) 1.18
Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival. Br J Cancer (2003) 1.16
New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects. Br J Cancer (2003) 1.10
NO-donating aspirin inhibits the activation of NF-kappaB in human cancer cell lines and Min mice. Carcinogenesis (2008) 1.08
Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion. Clin Exp Metastasis (2002) 1.01
Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer. Breast Cancer Res (2012) 0.92
The National Cancer Institute of Canada Clinical Trials Group MAP.3 trial: an international breast cancer prevention trial. Curr Oncol (2007) 0.89
Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1. J Virol (2006) 0.89
Benzo-[a]-pyrene increases invasion in MDA-MB-231 breast cancer cells via increased COX-II expression and prostaglandin E2 (PGE2) output. Clin Exp Metastasis (2005) 0.89
Corticotropin Releasing Factor promotes breast cancer cell motility and invasiveness. Mol Cancer (2009) 0.88
Rosmarinic acid antagonizes activator protein-1-dependent activation of cyclooxygenase-2 expression in human cancer and nonmalignant cell lines. J Nutr (2008) 0.86
Promoter methylation regulates cyclooxygenase expression in breast cancer. Breast Cancer Res (2004) 0.86
Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells. Br J Cancer (2009) 0.86
Potential role of cyclooxygenase-2 on the regulation of the drug efflux transporter ABCG2 in breast cancer cell lines. J Cancer Res Clin Oncol (2010) 0.84
Cyclo-oxygenase 2 and breast cancer prevention. Non-steroidal anti-inflammatory agents are worth testing in breast cancer. BMJ (1998) 0.84
Clinical value of cyclooxygenase-2 expression in human breast carcinoma. Cancer Res Treat (2004) 0.83
Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells. Int J Nanomedicine (2011) 0.82
Celecoxib and acetylbritannilactone interact synergistically to suppress breast cancer cell growth via COX-2-dependent and -independent mechanisms. Cell Death Dis (2011) 0.80
Genistein at maximal physiologic serum levels induces G0/G1 arrest in MCF-7 and HB4a cells, but not apoptosis. J Med Food (2013) 0.80
Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells. Breast Cancer Res (2007) 0.79
A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors. Mol Cancer Ther (2008) 0.78
Patterns of change over time and history of the inflammatory potential of diet and risk of breast cancer among postmenopausal women. Breast Cancer Res Treat (2016) 0.76
Role of Aspirin in Breast Cancer Survival. Curr Oncol Rep (2017) 0.75
Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev (2007) 1.99
Modulation of N-nitrosomethylurea-induced mammary tumor promotion by dietary fiber and fat. J Natl Cancer Inst (1991) 1.79
Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. J Clin Oncol (1993) 1.64
International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer (1986) 1.51
The influence of oestrogens on tryptophan metabolism in man. Clin Sci (1966) 1.37
Oral contraceptives, depression, and aminoacid metabolism. Lancet (1970) 1.24
Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients. Cancer Res (1980) 1.13
Dietary fat and mammary cancer. I. Promoting effects of different dietary fats on N-nitrosomethylurea-induced rat mammary tumorigenesis. J Natl Cancer Inst (1986) 1.13
The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines. Int J Oncol (1999) 1.11
Eicosanoids as mediators of linoleic acid-stimulated invasion and type IV collagenase production by a metastatic human breast cancer cell line. Clin Exp Metastasis (1996) 1.09
Aspects of tryptophan metabolism in health and disease: a review. J Clin Pathol (1972) 1.07
Enhanced angiogenesis and growth of 12-lipoxygenase gene-transfected MCF-7 human breast cancer cells in athymic nude mice. Cancer Lett (1998) 1.06
Plasma thyroid-stimulating hormone and thyroxine concentrations in breast cancer. Cancer (1978) 1.01
Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation. Cancer Res (2000) 1.01
Reduction of plasma tyrosine by oral contraceptives and oestrogens: a possible consequence of tyrosine aminotransferase induction. Clin Chim Acta (1970) 1.00
Effect of pyridoxine hydrochloride (vitamin B 6 ) upon depression associated with oral contraception. Lancet (1973) 0.98
Metabolic epidemiology of prostatic cancer. Prostate (1984) 0.97
A rationale for dietary intervention in postmenopausal breast cancer patients: an update. Nutr Cancer (1993) 0.97
Effects of reduced dietary linoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice. Nutr Cancer (1999) 0.96
Metabolism of tryptophan and niacin in oral contraceptives users receiving controlled intakes of vitamin B6. Am J Clin Nutr (1975) 0.96
Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice. Nutr Cancer (1997) 0.96
Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins. J Natl Cancer Inst (1987) 0.95
Urinary 4-pyridoxic acid, plasma pyridoxal phosphate, and erythrocyte aminotransferase levels in oral contraceptive users receiving controlled intakes of vitamin B6. Am J Clin Nutr (1975) 0.94
Dietary linoleic acid-stimulated human breast cancer cell growth and metastasis in nude mice and their suppression by indomethacin, a cyclooxygenase inhibitor. Nutr Cancer (1996) 0.93
Influence of dosage schedule on the biological characteristics of N-nitrosomethylurea-induced rat mammary tumors. Cancer Res (1980) 0.93
Nutrition and prostate cancer: a proposal for dietary intervention. Nutr Cancer (1994) 0.93
Protein kinase C and its isoforms in human breast cancer cells: relationship to the invasive phenotype. Int J Oncol (1998) 0.92
Excretion of urocanic acid following oral histidine in heart failure. Br Heart J (1966) 0.92
Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides. Prostate (1991) 0.92
Ovarian function in patients receiving adjuvant chemotherapy for breast cancer. Lancet (1977) 0.92
Erythrocyte aminotransferase activities in women using oral contraceptives and the effect of vitamin B 6 supplementation. Am J Clin Nutr (1973) 0.91
The role of fatty acids and eicosanoid synthesis inhibitors in breast carcinoma. Oncology (1995) 0.91
Response to a diet low in total fat in women with postmenopausal breast cancer: a pilot study. Nutr Cancer (1988) 0.90
Excretion of xanthurenic acid in the urine of women taking progestogen-oestrogen preparations. Nature (1966) 0.90
The influence of adrenocortical hormones and vitamins upon tryptophan metabolism in man. Clin Sci (1968) 0.90
Tryptophan metabolism as affected by anovulatory agents. Ann N Y Acad Sci (1969) 0.90
Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line. Prostate (1989) 0.90
Diet and breast cancer in causation and therapy. Cancer (1986) 0.89
Excretion of tryptophan metabolites as affected by pregnancy, contraceptive steroids, and steroid hormones. Am J Clin Nutr (1971) 0.89
Comparison of linoleic acid and eicosapentaenoic acid incorporation into human breast cancer cells. Lipids (1994) 0.89
The influence of sex, age and breast cancer on tryptophan metabolism. Clin Chim Acta (1967) 0.88
Angiogenesis in two human prostate cancer cell lines with differing metastatic potential when growing as solid tumors in nude mice. J Urol (1998) 0.88
Experience with a simple method for estrogen receptor assay in breast cancer. Clin Chim Acta (1976) 0.88
Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line. Prostate (1990) 0.88
Invasive capacity and regulation of urokinase-type plasminogen activator in estrogen receptor (ER)-negative MDA-MB-231 human breast cancer cells, and a transfectant (S30) stably expressing ER. Cancer Lett (1996) 0.87
Plasma prolactin levels in patients with breast cancer. Cancer (1981) 0.87
Vitamin B6 deficiency in cancer patients. Am J Clin Nutr (1977) 0.87
Nipple aspirates of breast fluid and the epidemiology of breast disease. Cancer (1985) 0.87
Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation? Melanoma Res (2001) 0.87
Tryptophan metabolism in carcinoma of the breast. Lancet (1967) 0.87
Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea. Cancer Res (1982) 0.87
Folic acid deficiency in leukemia and lymphomas. J Clin Pathol (1966) 0.86
Serum and breast duct fluid prolactin and estrogen levels in healthy Finnish and American women and patients with fibrocystic disease. Cancer (1986) 0.85
Oral contraceptives and tryptophan metabolism: effects of oestrogen in low dose combined with a progestagen and of a low-dose progestagen (megestrol acetate) given alone. J Clin Pathol (1972) 0.85
Effects of fatty acids on invasion through reconstituted basement membrane ('Matrigel') by a human breast cancer cell line. Cancer Lett (1993) 0.85
Endogenous secretion of epidermal growth factor peptides stimulates growth of DU145 prostate cancer cells. Cancer Lett (1991) 0.85
Modification of the effect of a gonadoliberin analog on 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by hormone replacement. Cancer Res (1979) 0.85
Rat mammary carcinoma regressions during suppression of serum growth hormone and prolactin. Anticancer Res (1984) 0.85
Effects of a high-complex-carbohydrate, low-fat, low-cholesterol diet on levels of serum lipids and estradiol. Am J Med (1985) 0.84
Dietary fat and mammary cancer. II. Modulation of serum and tumor lipid composition and tumor prostaglandins by different dietary fats: association with tumor incidence patterns. J Natl Cancer Inst (1986) 0.84
Experimental vitamin B 6 deficiency and the effect of oestrogen-containing oral contraceptives on tryptophan metabolism and vitamin B 6 requirements. Clin Sci (1972) 0.84
Effects of sex hormones on three glucocorticoid-inducible enzymes concerned with amino acid metabolism in rat liver. Endocrinology (1971) 0.83
The determination of 3-hydroxyanthranilic acid in urine by gas-iquid chromatography. Clin Chim Acta (1967) 0.83
Effect of varying proportions of dietary fat on the development of N-nitrosomethylurea-induced rat mammary tumors. Anticancer Res (1986) 0.83
Density-dependent regulation of epidermal growth factor receptor expression in DU 145 human prostate cancer cells. Prostate (1991) 0.81
Tobacco cessation outcomes in a cohort of patients attending a chest medicine outpatient clinic in Bangalore city, southern India. Indian J Med Res (2014) 0.81
The 12-lipoxygenase gene-transfected MCF-7 human breast cancer cell line exhibits estrogen-independent, but estrogen and omega-6 fatty acid-stimulated proliferation in vitro, and enhanced growth in athymic nude mice. Cancer Lett (1996) 0.81
Interactions between epidermal growth factor-mediated autocrine regulation and linoleic acid-stimulated growth of a human prostate cancer cell line. Prostate (1992) 0.81
Tryptophan metabolism and corticosteroids in breast cancer. Cancer (1974) 0.80
Effects of dietary menhaden oil, soy, and a cyclooxygenase inhibitor on human breast cancer cell growth and metastasis in nude mice. Nutr Cancer (1997) 0.80
Effect of oral contraceptives and vitamin B6 deficiency on carbohydrate metabolism. Am J Clin Nutr (1975) 0.80
Dietary factors and breast cancer. Cancer Surv (1986) 0.80
Influence of regional location of the inoculation site and dietary fat on the pathology of MDA-MB-435 human breast cancer cell-derived tumors grown in nude mice. Clin Exp Metastasis (1992) 0.79
Pernicious anemia with a normal serum vitamin B-12 level in a case of chronic granulocytic leukemia. Arch Intern Med (1966) 0.79
Diet and breast cancer. Hosp Pract (Off Ed) (1984) 0.79
Elevated bioactive prolactin in women at risk for familial breast cancer. Eur J Cancer Clin Oncol (1985) 0.79
Epidermal growth factor-like proteins in breast fluid and human milk. Life Sci (1988) 0.79
Plasma thyronine levels in carcinoma of the breast and colon. Arch Intern Med (1981) 0.79
The interactions between vitamin B6 and hormones. Vitam Horm (1978) 0.79
Effect of treatment with estrogen conjugates on endogenous plasma steroids. Obstet Gynecol (1977) 0.79
Urinary excretion of quinolinic acid and other tryptophan metabolites after deoxypyridoxine or oral contraceptive administration. Metabolism (1973) 0.79
Hormones in breast fluid. Breast Cancer Res Treat (1986) 0.79
Has breast self-examination had a fair trial? N Y State J Med (1985) 0.79
Diet and ovarian cancer. JAMA (1985) 0.79
Inhibition of tryptophan oxygenase in rat liver by steroid hormones. Biochem J (1970) 0.78
Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones. J Natl Cancer Inst (1987) 0.78
Vitamin B6 requirements of women using oral contraceptives. Am J Clin Nutr (1975) 0.78
Protective mechanisms of dietary fibers in nutritional carcinogenesis. Basic Life Sci (1993) 0.78
Plasma dehydroepiandrosterone sulfate, androstenedione and cortisol, and urinary free cortisol excretion in breast cancer. Eur J Cancer (1977) 0.78
Regulation of DU145 human prostate cancer cell proliferation by insulin-like growth factors and its interaction with the epidermal growth factor autocrine loop. Prostate (1994) 0.78
Influence of androgens upon tryptophan metabolism in man. Life Sci (1969) 0.78
Effects of dietary vitamin B 6 deficiency and oral contraceptives on the spontaneous urinary excretion of 3-hydroxyanthranilic acid. Am J Clin Nutr (1972) 0.78
Effect of oral contraceptives on plasma androgenic steroids and their precursors. Obstet Gynecol (1978) 0.77
Plasma triiodothyronine concentrations in breast cancer. Cancer (1979) 0.77
Induction of mammary tumors, estrous cycle abnormalities and endometrial hyperplasia in rats exposed to different doses of N-nitrosomethylurea. Eur J Cancer Clin Oncol (1982) 0.77
Effect of oral contraceptives and vitamin B6 supplements on alanine and glycine metabolism. Am J Clin Nutr (1976) 0.77
Transport and further metabolism on intermediate compounds of the tryptophan-nicotinic acid ribonucleotide pathway by rat small intestine. Biochim Biophys Acta (1968) 0.77
Clinical trials of dietary interventions to enhance cancer survival. Prog Clin Biol Res (1990) 0.77
Hormonal effects on the quantitative transplantation of monodispersed rat thyroid cells. Endocrinology (1980) 0.77